List of publications of Gianluca Bontempi
Peer-reviewed journal articles (156)
96.
Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.1052697.
Haibe-Kains, B., Desmedt, C., Rothé, F., Piccart-Gebhart, M., Sotiriou, C., & Bontempi, G. (2010). A fuzzy gene expression-based computational approach improves breast cancer prognostication. Genome biology, 11(2), R18. doi:10.1186/gb-2010-11-2-r18100.
Leignel, C., Hanson, E., Wolff, E., Caelen, O., Bontempi, G., Debeir, O., Leloup, T., Warzée, N., Simler, C., & Beumier, C. M. (2010). Detecting man-made structure changes to assist geographic data producers in planning their update strategy. The international archives of the photogrammetry, remote sensing and spatial information sciences, 38, 26-33.101.
Lamoral-Theys, D., Le Mercier, M., Le Calve, B., Rynkowski, M., Bruyère, C., Decaestecker, C., Haibe-Kains, B., Bontempi, G., Dubois, J., Lefranc, F., & Kiss, R. (2010). Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. Neoplasia (New York, N.Y.), 12(1), 69-79. doi:10.1593/neo.91360102.
Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Berger, W., Lefranc, F., & Kiss, R. (2009). Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia (New York, N.Y.), 11(5), 485-496.